- Energizer Holdings to acquire feminine hygiene business from J&J Family of Consumer Cos.
- Walmart makes plans for three new U.S. manufacturing projects
- Walmart convenes domestic sourcing summit in effort to help revitalize U.S. manufacturing
- Supreme Court issues 'pay-for-delay' ruling
- FDA, EMA program would allow joint inspections of generic drug manufacturing facilities
BLAUVELT, N.Y. — Concepts in Health on Wednesday reported it successfully has defended its MidNite Sleep Remedy patent from possible infringement by Contract Pharmacal, which had been manufacturing a store-brand version.
According to Concepts, Contract Pharmacal agreed to discontinue manufacturing and selling CVS Natural Sleep Aid or any substantially similar product. Additionally, CPC will not challenge the validity or enforceability of the MidNite patent (U.S. Patent 6,703,412).
“We are deeply gratified by the outcome of this settlement,” stated Holly Rosenthal, Concepts president. “We will continue to vigorously protect our intellectual property at whatever cost.”
Under the terms of the agreement, CPC did not admit liability for infringement of, or to the validity or enforceability of, the ‘412 patent. Financial and other terms of the settlement were not disclosed.